Suppr超能文献

癌细胞生长与化疗耐药中的Nrf2/HO-1轴

The Nrf2/HO-1 Axis in Cancer Cell Growth and Chemoresistance.

作者信息

Furfaro A L, Traverso N, Domenicotti C, Piras S, Moretta L, Marinari U M, Pronzato M A, Nitti M

机构信息

Giannina Gaslini Institute, Via Gerolamo Gaslini 5, 16147 Genoa, Italy.

Department of Experimental Medicine, University of Genoa, Via L. B. Alberti 2, 16132 Genoa, Italy.

出版信息

Oxid Med Cell Longev. 2016;2016:1958174. doi: 10.1155/2016/1958174. Epub 2015 Nov 30.

Abstract

The transcription factor, nuclear factor erythroid 2 p45-related factor 2 (Nrf2), acts as a sensor of oxidative or electrophilic stresses and plays a pivotal role in redox homeostasis. Oxidative or electrophilic agents cause a conformational change in the Nrf2 inhibitory protein Keap1 inducing the nuclear translocation of the transcription factor which, through its binding to the antioxidant/electrophilic response element (ARE/EpRE), regulates the expression of antioxidant and detoxifying genes such as heme oxygenase 1 (HO-1). Nrf2 and HO-1 are frequently upregulated in different types of tumours and correlate with tumour progression, aggressiveness, resistance to therapy, and poor prognosis. This review focuses on the Nrf2/HO-1 stress response mechanism as a promising target for anticancer treatment which is able to overcome resistance to therapies.

摘要

转录因子核因子红细胞2相关因子2(Nrf2)作为氧化应激或亲电应激的感受器,在氧化还原稳态中起关键作用。氧化或亲电试剂会导致Nrf2抑制蛋白Keap1发生构象变化,从而诱导转录因子的核转位,该转录因子通过与抗氧化/亲电反应元件(ARE/EpRE)结合,调节抗氧化和解毒基因如血红素加氧酶1(HO-1)的表达。Nrf2和HO-1在不同类型肿瘤中常被上调,并与肿瘤进展、侵袭性、治疗耐药性及预后不良相关。本综述聚焦于Nrf2/HO-1应激反应机制,将其作为一种有望克服治疗耐药性的抗癌治疗靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验